
SaveThePlanet 🌎
19.5K posts

SaveThePlanet 🌎
@USAPatriot16
I work on this one crazy problem and come here to kick back and dabble in daily happenings. Math says we can afford #MedicareForAll,




The Han Phan letter in Anthony's thread was neither related to @Capricor nor its Hope trials. I hope the company's legal team looks into these claims. $CAPR



🧵$CAPR longer thread, full report available now on substack, link in bio. in this thread I'll get into more of the details of why CAP-1002 is about to fail its ph3 topline





President Trump — my mom’s greatest desire has always been to see her kids get better. Even while battling Stage IV pancreatic cancer, she is still fighting for that day. Please read her letter to you. I ask you to intervene, as you have before, to cut through the red tape and help save my life — and the lives of thousands living with Duchenne Muscular Dystrophy. Please share this. We need every voice. @realDonaldTrump @WhiteHouse @JDVance washingtonexaminer.com/op-eds/3808452…




@DrMakaryFDA @US_FDA @SecKennedy If rare diseases are huge a priority, how come $CAPR received a CRL full of errors ???(blamed on AI) The study data had a p value of 0.0066 - statistically significant. A patient story from @Elijahjstacy below x.com/Elijahjstacy/s… Time for FDA to walk the talk


As the founder and leader of a DMD nonprofit, I meet and speak to patients and parents on a daily basis. They want deramiocel and it gives a lot of hope to patients, me included, starting to face cardiac decline. Every single day, weekends included, I have been working on helping get this approved. I am going up to bat for the DMD community and myself. I am now publicly calling on, as a patient, for other PATIENT advocacy groups and patients to start to speak publicly about their need and desire to get access to deramiocel. What I want to make clear is this isn’t just another little drug that will make small improvements, but a drug that can potentially rewrite the prognosis of DMD by adding decades to one’s life. #1 cause of death in DMD is cardiomyopathy and you’re potentially addressing that issue completely in one go. As a patient, it’d be very nice to remove/greatly reduce the biggest cause of death from my things to worry about. So let’s come together, DMD community, and make this happen. I have big plans to help get this through, but I’ll take more than just me. Let’s go win!

I recently met with Dr. Marty Makary, the new FDA Administrator, to discuss the agency’s new Rare Disease Evidence Principles (RDEP) — a framework designed to bring greater speed, clarity, and predictability to the review process for therapies targeting rare diseases with very small patient populations. This is a promising and much-needed step forward in accelerating treatments and improving outcomes for those living with rare conditions.

$CAPR Response to CRL There are no surprises in this letter. FDA staff must be embarrassed that they have to deal with Prasad's flawed judgment. The case made by $CAPR in this document is rock solid. I want to emphasize that I find the responses related to statistics to be particularly strong and to be consistent with the highest standards of statistical analysis. d1io3yog0oux5.cloudfront.net/_d095064bb2734…





I’m 22. I live with DMD. A treatment helped me hold onto my independence, graduate college, and live on my own. Now it might be taken away—not because it failed, but because we’re measuring the wrong things. Watch my story. Share it. I need your help. #DMD




Today, we approved a first-of-its-kind non-replicating adenoviral vector-based immunotherapy for the treatment of adult patients with recurrent respiratory papillomatosis. fda.gov/news-events/pr…






